The “passive” notification led to more patients with severe AS undergoing valve replacement, but more can be done still.

The recommendations are similar to those recently announced for TTVR, with the final NCD for T-TEER expected by July.

Sammy Elmariah, MD, MPH, and David Playford, MD, PhD discuss the ways technology and AI can be used to assist in better treatment and diagnosis of severe aortic stenosis.

While inconsistent dosing could have played a role, it still may be possible to identify the patients most likely to see ...

Nurse-led efforts to provide patients with ongoing lifestyle advice, education, and other resources reduced MACE by 30%.

LV thrombus is less of an issue now thanks to primary PCI and antithrombotics, but it still occurs in 9% of anterior MIs.

Liberal fluid intake was safe and suggestive of better health status: this should be enough to stop restricting patients to 1 ...

The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of ...

Experts are dismayed, disappointed, and confused, but many say this isn’t the end of cerebral embolic protection for TAVI.

Additional research is needed to determine whether this is due to direct drug effects or underlying patient factors.

Disappointment over a cardiology board, an FDA approval, meeting news, and advice for practice—it’s all here this month.